Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artivion Inc AORT

Healthcare Medical Devices
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment... see more

Recent & Breaking News (NYSE:AORT)

Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial

PR Newswire September 23, 2022

Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference

PR Newswire September 14, 2022

Artivion to Participate in Upcoming Investor Conferences

PR Newswire September 6, 2022

Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

PR Newswire August 24, 2022

Artivion Reports Second Quarter 2022 Financial Results

PR Newswire August 4, 2022

Artivion to Participate in Upcoming Investor Conferences

PR Newswire August 3, 2022

Artivion Initiates Enrollment in PERSEVERE Clinical Trial

PR Newswire July 27, 2022

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2022 Financial Results

PR Newswire July 21, 2022

Artivion to Participate in the UBS 2022 Global Healthcare Conference

PR Newswire May 16, 2022

Artivion Reports First Quarter 2022 Financial Results

PR Newswire May 5, 2022

ArtivionAnnounces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results

PR Newswire April 21, 2022

Artivion to Participate in the 21st Annual Needham Virtual Healthcare Conference

PR Newswire March 31, 2022

Artivion Publishes Inaugural Corporate Responsibility Report

PR Newswire March 14, 2022

Artivion to Host Investor & Analyst Day on March 23, 2022

PR Newswire March 9, 2022

Artivion to Participate in the Oppenheimer 32nd Annual Healthcare Conference

PR Newswire March 3, 2022

Artivion Reports Fourth Quarter and Full Year 2021 Financial Results

PR Newswire February 17, 2022

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2021 Financial Results

PR Newswire February 3, 2022

Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results in The Annals of Thoracic Surgery

PR Newswire January 31, 2022

CryoLife Announces Corporate Rebranding and Changes Name to Artivion

PR Newswire January 18, 2022

CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

PR Newswire November 9, 2021